Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company provide...
Q2 2026
Aug 19, 2026
Q1 2026
May 5, 2026
FY 2025
Mar 31, 2026
Q4 2025
Q3 2025
Nov 13, 2025